CELL TECHNOLOGIES IN OBSTETRICS, GYNECOLOGY, NEONATOLOGY AND PEDIATRIC NEUROLOGY

Kletochnie_2013_small

November 7, 2013 Institute of Cellular Therapy and Coordination Centre for Transplantation of Organs, Tissues and Cells of the Ministry of Health held a scientific-practical conference with international participation, which was devoted to the use of cellular technology in obstetrics, gynecology, neonatology and pediatric neurology.

Uptodate development of science in the field of physiology of stem cells of different origin, as well as technologies for the production, cultivation, genetic transformation, and cryopreservation of cells and tissues contributed to the emergence of new, previously unavailable methods for diagnosis and treatment of obstetric and gynecological pathology, hypoxic-ischemic encephalopathy and neonatal cerebral palsy.

It is known that pregnancy disorders, congenital diseases and malformations of the fetus, as well as obstetric aggression lead to such serious consequences in the newborn, as hypoxic-ischemic encephalopathy, which in future becomes the cause of cerebral palsy. The use of stem cells of different origin, including autologous and allogeneic cord blood, which contains stem cells of various types, in experimental and clinical practice has demonstrated positive results. Widespread introduction into clinical practice of the methods of cell therapy will give physicians new treatment of socially significant diseases, namely infertility, hypoxic-ischemic encephalopathy, and cerebral palsy.

Topics of the conference were:

  • Cell technologies in the treatment of consequences of obstetric aggression.
  • Placental stem cell markers in the diagnosis of pre-eclampsia.
  • Stem cells of the placenta.
  • Stem cells and microchimerism.
  • Stem cells and reproduction.
  • Clinical use of umbilical cord blood in hypoxic-ischemic encephalopathy in newborns.
  • The experimental data on the use of different types of stem cells in models of hypoxic-ischemic encephalopathy newborns.
  • Clinical data of cord blood use in children with cerebral palsy .
  • Biotechnological approaches in working with cells of different origin for use in research and clinical practice.

Besides leading national experts, internationally renowned scientists, including Professor James Carroll (USA ), Prof. MinYung Kim (Korea)  gave lectures at the conference at the invitation of the Institute of Cell Therapy. Dr. Dzhiun Lee (Singapore) and Dr. Dariusz Boruczkowski (Poland) also shared experience of clinical application of stem cells.

The conference is included in the “Register of congresses, symposia and scientific conferences to be held in 2013 of the Ministry of Health of Ukraine, National Academy of Medical Sciences of Ukraine, the Ukrainian Center of Scientific Medical Information and Patent and Licensing Work of the Scientific Coordination Control Department of NAMS”  under the number 173.

CONFERENCE WEBSITE : http://cellconference.info/

Scientific Programm of International Conference

8.30 – 9.30 Registration
9.30 – 9.40 Opening Ceremony

Session I 9.40 – 11.15

9.40 – 10.10 Stem cells for acute neonatal hypoxic-ischemic injury
James Edwin Carroll
Georgia Regents University, Augusta, USA
10.10 – 10.40 Autologous cord blood cells for infants with hypoxic-ischemic encephalopathy – pilot study of feasibility and safety
Jiun Lee
Department of Neonatology, National University Health System, Singapore
10.40 – 11.10 Famicord Group experience in haematopoietic and mesenchymal stem cells transplantation
Dariusz Boruczkowski
Famicord Group, Warszawa, Poland
11.15 – 11.45 Coffee Break

Session II 11.45 – 13.15

11.45 – 12.15 Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy
MinYoung Kim
CHA University, Seongnam-si, Republik of Korea
12.15 – 12.45 Umbilical cord blood stem cells for cerebral palsy
James Edwin Carroll
Georgia Regents University, Augusta, USA
12.45 – 13.15 Results of neurotransplantation in patients with cerebral palsy Vitalii Tsymbalyuk
Romodanov Institute of Neurosurgery, Kyiv, Ukraine
13.15 – 13.35 Selection of the recipient with cerebral palsy for cell therapy Stanislav Evtuschenko
Department of Pediatric and General Neurology, DonNMU, Donetsk, Ukraine
13.40 – 14.45 Lunch Break

Session III 14.45 – 16.00

14.45 – 15.15 Placental stem cell: biological characteristics and potential clinical application
Volodymyr Shablii
Institute of Cell Therapy, Kiev, Ukraine
15.15 – 15.35 Experimental Approaches to Study Therapeutic Potential of Stem Cells at Perinatal Pathology of CNS
Oleg Tsupikov
Bogomoletz Institute of Physiology, Kiev, Ukraine
15.35 – 15.55 Cryopreservation of ovarian tissue to save the fertility in young adults with cancer and other pathology
Peter Nemtinov
Institute of Cell Therapy, Kiev, Ukraine
16.00 – 16.30 Coffee Break

Session IV 16.30 – 18.00

16.30 – 16.50 Pathogenesis of endothelial dysfunction of the fetoplacental complex in complicated pregnancy
Volodymyr Klimov
Luhansk Regional Perinatal Center, Luhansk, Ukraine
16.50 – 17.10 Endotelial Progenitor Cells and Preeclampsia
Vitaliy Kyryk
Institute of Genetic and Regenerative Medicine NAMS, Kiev, Ukraine
17.10 – 18.00 Discussion
18.30 Welcome dinner

Partners

genex_logo_200x100

 

 

 

logo_vilan_200x100

 

 

 

logo_adanit

 

 

 

logo_medpharmconnect_100x100 medprosvita_logo logo CTTE_120x90x logo_tg_2 logo DD_120x90x logo_Labprice_120x90x logo USW_120x90x_1 logo PL_120х90

 

 

 

 

 

 

 

 

 

 

No Comments Yet.

Leave a comment

You must be logged in to post a comment.